Insights

In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.

Pharmatica image of a glass globe illuminated from within by bright yellow light, surrounded by blue data lines, symbolising AI bringing light, intelligence, and innovation to global healthcare through the Anthropic and Gates Foundation Partnership.

Artificial Intelligence in Healthcare AI Pharma AI & Machine Learning

Anthropic’s Gates Foundation Partnership and Healthcare AI

Nicole Dale

Pharmatica image representing AI and machine learning in sterile pharmaceutical manufacturing. The image shows precision glass ampoules with a digital data mesh overlay, symbolising AI-driven quality and contamination detection.

Sterile Manufacturing Quality Continuous Manufacturing

Can AI and Machine Learning in Sterile Manufacturing Improve Quality?

Nicole Dale

Optimising clinical trial data collection Pharmatica image representing fit-for-purpose evidence generation.

Clinical Data Clinical Outcomes Clinical Trial Design

Optimising Clinical Trial Data Collection for Better Decisions

Nicole Dale

Pharmatica image showing a pharmaceutical R&D portfolio management meeting reviewing drug discovery pipeline progression, translational science, and pharmaceutical R&D success rates using evidence-based portfolio strategy.

What Drives Pharmaceutical R&D Success? New Benchmarking Reveals Why Some Drug Pipelines Outperform Others

Pharmatica image showing a clinical geneticist using LLM-assisted rare disease diagnosis tools to analyse genome sequencing data and generate evidence-based diagnostic hypotheses for precision medicine.

Can Large Language Models Solve More Rare Disease Genomes?

Pharmatica image showing modular pharmaceutical manufacturing using continuous pharmaceutical manufacturing processes, interconnected production modules, and Process Analytical Technology to improve flexible drug manufacturing.

Modular Pharma Factories: The Next Step for Continuous Manufacturing?

Explore All Insights

Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.

Nicole Dale

Anthropic’s Gates Foundation Partnership and Healthcare AI

See how Anthropic's Gates Foundation partnership and Long-Term Benefit Trust could lead the way in shaping responsible AI governance across healthcare innovation.

Nicole Dale

Optimising Clinical Trial Data Collection for Better Decisions

Learn how optimised clinical trial data collection improves data quality, reduces protocol and patient burden, and supports smarter clinical development.

Nicole Dale

Can Large Language Models Solve More Rare Disease Genomes?

LLM-assisted rare disease re-assessment improved genomic analysis, increasing diagnostic yield and supporting clinician-led precision medicine and possibly drug development.

Nicole Dale

Can Large Language Models Solve More Rare Disease Genomes?

LLM-assisted rare disease re-assessment improved genomic analysis, increasing diagnostic yield and supporting clinician-led precision medicine and possibly drug development.

Nicole Dale

FAST-EU Pilot: Can Europe Finally Accelerate Multinational Clinical Trials?

Pharmatica image representing the FAST-EU Pilot supporting multinational clinical trials through coordinated European regulatory collaboration, accelerating clinical trial approvals under the EU Clinical Trials Regulation (CTR).

The FAST-EU Pilot aims to accelerate multinational clinical trials through faster coordinated assessments, supporting Europe’s 2030 clinical research ambitions.

Nicole Dale

Foundational AI In Cell and Gene Therapy Development Success

Pharmatica image representing AI in cell and gene therapy development success through improving drug discovery, viral vector engineering, manufacturing, and predictive quality control.

Discover why AI in cell and gene therapy is necessary for successful development by improving drug discovery, viral vector engineering, manufacturing, and quality control.

Nicole Dale

Eli Lilly and AtaiBeckley: AI and Psychedelic Biotech Converge

Pharmatica image showing an anatomically accurate human brain with subtle neural activation inspired by functional MRI imaging, representing psychedelic biotech, mental health therapeutics, CNS drug discovery, and AI-enabled pharmaceutical innovation.

Eli Lilly's acquisition of Peter Thiel’s backed AtaiBeckley highlights growing investment in psychedelic biotech and the future of CNS drug discovery.

Nicole Dale

One Pivotal Trial for FDA Approval? Success Depends on Trial Design

Pharmatica image of a modern pharmaceutical regulatory affairs workspace representing documentation, compliance, and submission processes essential for FDA drug approval. The scene shows three binders labeled “Regulatory Affairs,” “Submissions,” and “Compliance” on a clean office desk with documents and a pen in the foreground, while a blurred meeting of professionals is visible through a glass wall in the background. The composition conveys administrative precision and regulatory science underpinning.

One pivotal trial for FDA approval could accelerate drug development, reshape clinical trial strategy, and change the pharmaceutical regulatory landscape.

Nicole Dale

Claude Science: An Operating System for AI-Driven Pharma R&D

Pharmatica photo‑realistic representation of scientists collaborating in a unified AI‑driven pharmaceutical research environment using Claude Science, integrating genomics, structural biology, cheminformatics, and AI-assisted pharmaceutical research

Claude Science is a new AI R&D tool for drug discovery, integrating 60-plus scientific databases into one place. Here is what pharma R&D teams need to know.

Nicole Dale

Europe’s Life Sciences Strategy. A New Era of Innovation?

Pharmatica picture of European pharmaceutical innovation showing biotechnology research, advanced manufacturing, artificial intelligence, and regulatory collaboration supporting the European Life Sciences Strategy.

The new European Life Sciences Strategy aims to accelerate pharmaceutical innovation through investment, regulatory reform, biotechnology, and AI capabilities.

Nicole Dale

Deep Learning in Clinical Trials for 2026 and Beyond

Pharmatica representation of deep learning in clinical trials, especially AI‑driven patient recruitment in clinical trials with a realistic laboratory setting and data visualisations, global site maps, and trial analytics dashboards illustrating machine learning in clinical trials, patient recruitment AI, and adaptive trial design AI.

Deep learning is changing how clinical trials are designed, run, and analysed in 2026. Examine the tools, outcomes, and strategic risks shaping adoption.

Nicole Dale

AI and Neuroscience. Why Big Pharma Is Betting on the Brain

Pharmatica’s AI in neuroscience graphical concept showing a digital brain connected to pharmaceutical research, precision psychiatry, biomarkers, and advanced artificial intelligence technologies.

AI in neuroscience is driving big pharma investment. Discover how AI neuroscience platforms are driving precision psychiatry and psychedelic therapeutics.

Topic